Back to Trials
NCT07586397NARecruiting

HIPS Feasibility Randomized Controlled Trial

Massachusetts General Hospital

Start Date

7/20/2026

Completion Date

6/1/2028

Summary

The goal of this clinical trial is to conduct a randomized controlled trial (RCT) to test the feasibility of two dose- and time-matched pain management programs, delivered via live video, for adults with chronic (lasting at least 3 months) and non-arthritic hip-related pain (HRP). Following pre-determined benchmarks, findings from this trial will be used to assess the feasibility, credibility, and acceptability of both programs (HIPS-1, HIPS-2). In preparation for a future clinical trial powered to test efficacy, we will optimize the protocol for patient recruitment, study protocol, and fidelity materials.

Detailed Description

Aim: Conduct an RCT testing the feasibility of two dose- and time-matched pain management programs, delivered via live video, for adults with chronic (lasting at least 3 months) and non-arthritic HRP. The ultimate goal of this research is to assess the feasibility, credibility, and acceptability of both interventions (HIPS-1, HIPS-2) and optimize the program and study methodology in preparation for a future RCT powered to assess efficacy. HIPS-1 and HIPS-2 Interventions: Both programs consist of 6 sessions delivered via live video (i.e., Zoom) and are tailored to the needs of patients with non-arthritic HRP seeking physical therapy/rehabilitation. Both programs aim to improve the management of the subjects' HRP by providing helpful information. Sessions, regardless of program assignment, are held weekly. In between sessions, subjects complete a brief check-in survey. Participants will complete the baseline assessment (i.e., digital self-report survey battery). Following the baseline assessment, participants will be randomized to one of the two conditions (HIPS-1, HIPS-2) and complete their 6 program sessions within approximately 6-weeks. Participants will complete additional survey assessments directly following their final program sessions, and once more, 6 months later. Assessments: Baseline (0 weeks), post-test (6 weeks), and 6-month follow-up (30 weeks) survey assessments.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: 1. Presenting with chronic (lasting ≥3 months) hip joint-related pain 2. Fluent in English 3. Age ≥18yr \[If ≥45yr, the physician will confirm no osteoarthritis via X-ray (Kellgren Lawrence \[KL\] grade 0-1)\] 4. Score ≥3 for current hip pain on the Pain-VAS 5. Psychological risk factor for the maintenance of pain by meeting ≥1 of the criteria listed below: 1. Score ≥ 20 on the PCS 2. Score ≤ 40 on the PSEQ 3. Score ≥ 17 on the TSK-11 6. Exhibits sedentariness or dissatisfaction with physical activity by meeting ≥1 of the criteria listed below: 1. Physically active \< 150mins/week according to the IPAQ-SF 2. Hip pain interferes with the ability to be physically active 3. Dissatisfaction with the current physical activity level Exclusion Criteria: 1. Previous surgery on the symptomatic (painful) hip 2. Current pain referred from the lower back

Interventions

BEHAVIORAL

HIPS-1

BEHAVIORAL

HIPS-2

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Hip Pain ChronicHip PainPhysical Medicine and Rehabilitation

Locations

Massachusetts General Hospital

Boston, Massachusetts 02114

United States